Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
May 18, 2010Next-generation system strengthens Company's endometrial ablation portfolio for the treatment of menorrhagia
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its Genesys HTA™ System for the...
-
May 13, 2010
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration clearance of the ACUITY Break-Away™ Lead Delivery...
-
May 12, 2010Approval includes specific indication for treatment of diabetic patients
Boston Scientific Corporation (NYSE: BSX) today announced it has received CE Mark approval for its TAXUS® Element™ Paclitaxel-Eluting Coronary...
-
May 11, 2010
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval for LATITUDE 6.0, a software upgrade to...
-
May 10, 2010
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and sponsored research at the 31st Annual...
-
May 4, 2010Results of study using Boston Scientific's WallFlex® Duodenal Stent presented at Digestive Disease Week®
Boston Scientific Corporation (NYSE: BSX) today announced results from a study demonstrating that endoscopic duodenal stenting is...
-
May 3, 2010EVIDENCE Trial to study Boston Scientific's Precision Plus™ Spinal Cord Stimulator System
Boston Scientific Corporation (NYSE: BSX) today announced the start of patient enrollment in the EVIDENCE Clinical Trial, which compares the...
-
Apr 30, 2010Positive results to be presented for SpyGlass® Direct Visualization System, Radial Jaw® 4 Biopsy Forceps and WallFlex® Duodenal Stents
Boston Scientific Corporation (NYSE: BSX) today announced that multiple clinical abstracts examining the diagnostic and therapeutic utility of its...
-
Apr 29, 2010Educational forum includes lab training sessions and online community for urogynecologists, urologists and surgical gynecologists
Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Pelvic Floor Institute™ -- a unique training forum and online...
-
Apr 27, 2010
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. District Court in Minnesota declined to accept the plea agreement between...
-
Apr 26, 2010Company records $1.8 billion goodwill impairment charge
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the first quarter ended March 31, 2010, as well as guidance for...
-
Apr 22, 2010Major advance in guidewire technology provides exceptional torque and flexibility for coronary procedures
Boston Scientific Corporation (NYSE: BSX) today announced the launch of its new Kinetix™ Guidewire for use in percutaneous coronary intervention...
-
Apr 21, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming Bank of America Merrill Lynch Health Care Conference in New...
-
Apr 19, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming Deutsche Bank Health Care Conference in Boston on May 4. Ray...
-
Apr 19, 2010Exclusive agreement promotes access to testing solutions for female urinary incontinence
Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a four-year exclusive marketing agreement with Bladder Health...
-
Apr 15, 2010Boston Scientific to Immediately Resume Distribution of COGNIS® CRT-Ds and TELIGEN® ICDs in the U.S.
Boston Scientific Corporation (NYSE: BSX) today announced that it has received U.S. Food and Drug Administration (FDA) clearance for the two...
-
Apr 15, 2010
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2010...
-
Mar 18, 2010Company's CRT-Ds recommended for asymptomatic and mild heart failure patients
Boston Scientific Corporation (NYSE: BSX) today announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA)...
-
Mar 16, 2010Trials to evaluate small vessel and long lesion versions of platinum chromium PROMUS® Element™ Stent System
Boston Scientific Corporation (NYSE: BSX) today announced the completion of patient enrollment in the Small Vessel and Long Lesion trials of its...
-
Mar 15, 2010Boston Scientific applies to FDA for expanded indications for TAXUS Express and TAXUS® Liberte® Stents in AMI patients
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of one-year subset data from the HORIZONS AMI trial...
-
Mar 15, 2010
Boston Scientific Corporation (NYSE: BSX) today announced 12-month results from its PERSEUS clinical program that demonstrated...
-
Mar 15, 2010
Boston Scientific Corporation (NYSE: BSX) announced today that it has stopped shipment and is retrieving field inventory of all its implantable...
-
Mar 11, 2010First and only premounted, balloon-expandable stent approved specifically for use in iliac arteries
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved its Express® LD Iliac...
-
Mar 10, 2010Clinical data presentations to include 12-month results for third-generation TAXUS® Element™ drug-eluting stent
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements at the 59th Annual...
-
Feb 23, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming RBC Capital Markets Health Care Conference in New York City....